Decitas 30 Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Decitabine (30mg)
Overview Decitas 30 Injection
Decitas 30 Injection treats acute myeloid leukemia (AML), a type of blood cancer, and myelodysplastic syndrome (MDS). Its use may extend to other conditions as directed by a physician. Often administered intravenously as part of combination chemotherapy, the dosage and frequency are determined by your doctor based on your specific condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. While therapeutic benefits might not be immediately apparent, discontinue use only under medical guidance. Common side effects encompass nausea, vomiting, diarrhea, headache, fever, and pneumonia. The medication can lower blood cell counts, increasing infection risk, necessitating regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or the use of antimicrobial agents. Interaction with other medications is possible; inform your doctor of all concurrent medications. Pregnancy and breastfeeding are contraindicated. Both partners should employ reliable contraception throughout the treatment period to prevent conception.
Uses of Decitas 30 Injection
Bone marrow failure disorders | Hematologic malignancy
Major Benefits of Decitas 30 Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Decitas 30 Injection:
- Nausea
- Vomiting
- Headache
- Fever
- Lung infection
- Decreased white blood cell count (neutrophils)
- Nosebleeds
- Anemia (low number of red blood cells)
- Low blood platelets
- Diarrhea
- Pneumonia
How to use Decitas 30 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Decitas 30 Injection works:
Decitas 30 Injection disrupts cancer cell proliferation by substituting essential DNA and RNA components, thereby halting their growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Decitas 30 Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Decitas 30 Injection during pregnancy carries confirmed risks to the fetus. Nevertheless, in exceptional life-threatening cases, a physician might deem its use justifiable if potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Decitas 30 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Decitas 30 Injection may induce adverse reactions that impair driving capabilities. Fatigue or weakness following Decitas 30 Injection may also compromise driving safety.
KidneyCAUTION
Administering Decitas 30 Injection to individuals with impaired renal function requires careful monitoring. Dosage modification for Decitas 30 Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Decitas 30 Injection's use in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Decitas 30 Injection :
NA
Facts to Know About Decitas 30 Injection
| Label | Value |
|---|---|
| Chemical Type | Azacitidine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Metabolic Antagonists |
3,018 People bought this recently
